Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo after First-Line Chemotherapy in Patients with Metastatic Urothelial Cancer
- Matthew D. Galsky
- , Amir Mortazavi
- , Matthew I. Milowsky
- , Saby George
- , Sumati Gupta
- , Mark T. Fleming
- , Long H. Dang
- , Daniel M. Geynisman
- , Radhika Walling
- , Robert S. Alter
- , Mohamad Kassar
- , Jue Wang
- , Shilpa Gupta
- , Nancy Davis
- , Joel Picus
- , George Philips
- , David I. Quinn
- , G. Kenneth Haines
- , Noah M. Hahn
- , Qianqian Zhao
- Icahn School of Medicine at Mount Sinai
- Ohio State University
- University of North Carolina
- SUNY Buffalo
- University of Utah
- Virginia Oncology Associates
- Ochsner Medical Center
- American Health Network
- Rutgers - The State University of New Jersey, Newark
- University of Münster
- University of Arizona
- Cleveland Clinic Foundation
- Vanderbilt University
- Washington University St. Louis
- MedStar Georgetown University Hospital
- University of Southern California
- Johns Hopkins University
- University of Wisconsin-Madison
- City of Hope National Medical Center
Research output: Contribution to journal › Article › peer-review
120
Scopus
citations